[CUSIP No. 16938C106 13D 1 Essence International Investment Limited NAMES OF REPORTING PERSONS: N/A I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP o (a) o (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS WC 5 6 CITIZENSHIP OR PLACE OF ORGANIZATION British Virgin Islands NUMBER OF SHARES BENEFICIALLY]
[CUSIP No. 16938C106 13D 1 Essence International Investment Limited NAMES OF REPORTING PERSONS: N/A I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP o (a) o (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS WC 5 6 CITIZENSHIP OR PLACE OF ORGANIZATION British Virgin Islands NUMBER OF SHARES BENEFICIALLY]
[reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities that]
[reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities that]
[Registration No. 333- FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue, Xianyang, Shaanxi Province, People’s Republic of China 712046 Biostar Pharmaceuticals, Inc. 2013 Equity Incentive Plan (Full title of the plan) Ronghua Wang President and Chief] [BIOSTAR PHARMACEUTICALS, INC. 2013 EQUITY INCENTIVE PLAN, INC. ______________________ Section 1. Purpose. The purpose of the Biostar Pharmaceuticals, Inc. 2013 Equity Incentive Plan (the “Plan”) is to attract and retain outstanding individuals as Key Employees, Directors and Consultants of the Company and its Subsidiaries, to recognize the contributions made to the Company and its Subsidiaries by Key Employees, Directors and] [[Schiff Hardin LLP Letterhead] July 17, 2014 Biostar Pharmaceuticals, Inc. No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China Ladies and Gentlemen: EX-5.1 3 ex5-1.htm EX-5.1] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 dated July 17, 2014 of Biostar Pharmaceuticals, Inc. of our report dated March 31, 2014 relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K]
[Registration No. 333- FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue, Xianyang, Shaanxi Province, People’s Republic of China 712046 Biostar Pharmaceuticals, Inc. 2013 Equity Incentive Plan (Full title of the plan) Ronghua Wang President and Chief] [BIOSTAR PHARMACEUTICALS, INC. 2013 EQUITY INCENTIVE PLAN, INC. ______________________ Section 1. Purpose. The purpose of the Biostar Pharmaceuticals, Inc. 2013 Equity Incentive Plan (the “Plan”) is to attract and retain outstanding individuals as Key Employees, Directors and Consultants of the Company and its Subsidiaries, to recognize the contributions made to the Company and its Subsidiaries by Key Employees, Directors and] [[Schiff Hardin LLP Letterhead] July 17, 2014 Biostar Pharmaceuticals, Inc. No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China Ladies and Gentlemen: EX-5.1 3 ex5-1.htm EX-5.1] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 dated July 17, 2014 of Biostar Pharmaceuticals, Inc. of our report dated March 31, 2014 relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K]
[Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho Senior Vice President & Chief Financial Officer 2014 Second Quarter Earnings Conference July 16, 2014 © 2014 TSMC, Ltd Agenda TSMC Property l Welcome Elizabeth Sun l 2Q14 Financial Results and 3Q14 Outlook Lora Ho l Key Messages Morris Chang l Q&A © 2014 TSMC, Ltd]
[o x s TABLE OF CONTENTS PART I. FINANCIAL INFORMATION PAGE Item 1. Interim Financial Statements Consolidated Balance Sheets as of March 31, 2014 (Unaudited) and December 31, 2013 F1-F2 Consolidated Statements of Operations and Comprehensive (Loss)/Income for the Three Months Ended March 31, 2014 and 2013 (Unaudited) F3-F4 Consolidated Statements of Cash Flows F5-F6 Notes to Consolidated Financial Statements] [CERTIFICATION I, Handong Cheng, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of ChinaNet Online Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Zhige Zhang certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of ChinaNet Online Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. July 17, 2014 Handong Cheng Chief Executive Officer Zhige Zhang Chief Financial Officer (Principal Accounting and Financial Officer)]
[Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho Senior Vice President & Chief Financial Officer 2014 Second Quarter Earnings Conference July 16, 2014 © 2014 TSMC, Ltd Agenda TSMC Property l Welcome Elizabeth Sun l 2Q14 Financial Results and 3Q14 Outlook Lora Ho l Key Messages Morris Chang l Q&A © 2014 TSMC, Ltd]
[o x s TABLE OF CONTENTS PART I. FINANCIAL INFORMATION PAGE Item 1. Interim Financial Statements Consolidated Balance Sheets as of March 31, 2014 (Unaudited) and December 31, 2013 F1-F2 Consolidated Statements of Operations and Comprehensive (Loss)/Income for the Three Months Ended March 31, 2014 and 2013 (Unaudited) F3-F4 Consolidated Statements of Cash Flows F5-F6 Notes to Consolidated Financial Statements] [CERTIFICATION I, Handong Cheng, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of ChinaNet Online Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Zhige Zhang certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of ChinaNet Online Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. July 17, 2014 Handong Cheng Chief Executive Officer Zhige Zhang Chief Financial Officer (Principal Accounting and Financial Officer)]
